Regadenoson R-T Perfusion Imaging Trial



Status:Archived
Conditions:Peripheral Vascular Disease, Cardiology, Women's Studies
Therapuetic Areas:Cardiology / Vascular Diseases, Reproductive
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:May 2009
End Date:December 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Regadenoson Real Time Perfusion Imaging Trial


To exam the feasibility and accuracy of RTPE during vasodilator stress with 400micrograms of
the A2A Receptor agonist Regadenoson for detection of significant coronary artery disease
(CAD) in patients scheduled to undergo coronary angiography. Sensitivity, specificity , and
accuracy of perfusion and wall motion analysis to identify a coronary stenosis> 50% in
diameter by quantitive angiography will be analyzed



We found this trial at
2
sites
University of Nebraska Medicial Center
Omaha, Nebraska 68105
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Mayo Clinic Rochester
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials